Figure 3From: Progression-free survival at 2 years is a reliable surrogate marker for the 5-year survival rate in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy Five-year survival rates of patients who achieved each outcome. The bars indicate 95% confidence intervals.Back to article page